KIM-1, IGFBP7, Galectin 3 and GDF-15: Updates on biomarkers in heart failure (HF) patients

22. 06. 2022

Meijers WC et al. Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC). Eur J Heart Fail. 2021 Oct;23(10):1610-1632.

Authors focus on non-cardiac markers procalcitonin, NGAL, KIM-1, IGFBP-7, soluble suppression of tumorigenicity 2 (sST2), galectin-3, growth differentiation factor-15 (GDF-15), cluster of differentiation 146 (CD146), neprilysin, adrenomedullin (ADM), and also discuss proteomics and genetic-based risk scores. Among these parameters in HF patients, KIM-1 was  proposed to differentiate between AKI and acute tubular necrosis, and Galectin-3 was used for the assessment of a risk for new-onset HF and all-cause mortality in patients with HFpEF (heart failure with preserved ejection fraction).

Blog

News

KREBS VON DER LUNGEN-6 (KL-6): PROVEN MARKER OF INTERSTITIAL LUNG DISEASE

30. 11. 2023

BACKGROUND Krebs von den Lungen-6 (KL-6) is a high-molecular mucin-like glycoprotein, encoded by MUC1 gene. KL-6/MUC1 regulates cell-cell...

Monomeric CRP: A KEY MOLECULE DRIVING DEVELOPMENT OF ALZHEIMER’S DISEASE?

26. 03. 2023

BACKGROUND C-reactive protein (CRP) is a multipotent protein that undergoes conformational changes between circulating native pentameric...

Monomeric CRP: A NEW PLAYER IN EVALUATION OF CARDIOVASCULAR RISK?

26. 03. 2023

BACKGROUND: CRP AND MONOMERIC CRP (mCRP) IN INFLAMMATION Although CRP is an independent risk factor for CVD and offers a prognostic...

© 2024 All rights reserved.